文献速递睡眠呼吸障碍

可调热塑性口腔矫治器与持续气道正压治疗阻塞性睡眠呼吸暂停的比较

Adjustable thermoplastic oral appliance versus positive airway pressure for obstructive sleep apnea.
PubMed 文献 · Laryngoscope · 2017-07-17

结果显示两种治疗在改善生活质量(FOSQ评分)方面无显著差异,但AT-MAS在降低呼吸暂停低通气指数(AHI)方面不如CPAP有效。

要点

  • AT-MAS与CPAP在改善短期生活质量方面效果相似。
  • CPAP降低AHI优于AT-MAS(2.56 vs 12.92 events/hour)。
  • AT-MAS常见副作用为下颌疼痛和唾液过多,CPAP为口干和携带不便。

核心结论

  • 两种设备均能相似地改善短期生活质量,但AT-MAS在改善睡眠测试参数方面不如CPAP有效。
  • AT-MAS可能仅作为临时治疗选择。

主要发现

  • FOSQ评分在两种治疗间无显著差异,全局评分差异为0.57(95%CI:-0.15至1.29)。
  • 平均AHI从治疗前的39.2±2.53降至CPAP的2.56±0.49和AT-MAS的12.92±2.05 events/hour(P<.05)。
  • 7例退出:5例AT-MAS不耐受,2例失访。

关键数值与推荐

  • 纳入标准:年龄≥18岁,AHI≥5 events/hour,氧饱和度≥70%。
  • 排除标准:颞下颌关节疾病、严重牙周炎、牙齿不足、不稳定疾病。

临床怎么用

  • 对于不能耐受CPAP的患者,AT-MAS可作为临时替代治疗,但需告知其降低AHI效果不如CPAP。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: To compare outcomes of continuous positive airway pressure (CPAP) and the adjustable thermoplastic mandibular advancement splint (AT-MAS) for obstructive sleep apnea treatment. STUDY DESIGN: Randomized crossover, noninferiority, tertiary center setting. METHODS: Fifty patients with a mean age of 49.5 ± 10.6 years were enrolled. Inclusion criteria were age ≥18 years, apnea-hypopnea index (AHI) ≥5 events/hour, and oxygen saturation ≥70%. Exclusion criteria were temporomandibular joint disorders, severe periodontitis, inadequate teeth, and unstable medical diseases. Treatment intolerance was considered a failure. Two-week periods without treatment were followed by questionnaires and randomization into two groups: CPAP/AT-MAS (25) and AT-MAS/CPAP (25). After 6 weeks of intervention, questionnaires and home WatchPAT monitoring were performed. Following each 2-week washout period, patients crossed over to the other treatment followed by similar procedures. Primary outcomes involved the scores from the Functional Outcomes of Sleep Questionnaire (FOSQ). Secondary outcomes were AHI, side effects, and treatment adherence. RESULTS: Seven patients withdrew from this study: five (AT-MAS intolerance) and two (lost follow-up). There was no significant difference among FOSQ scores, particularly on global scores, between both treatments (0.57, 95% confidential interval of difference: -0.15 to 1.29). Mean AHI decreased from pretreatment 39.2 ± 2.53 to 2.56 ± 0.49 and 12.92 ± 2.05 events/hour while using CPAP and the AT-MAS, respectively (P < .05). Most common side effects of CPAP were dry throat and inconvenience to carry, whereas those of the AT-MAS were jaw pain and excessive salivation. CONCLUSIONS: Both devices improved short-term quality of life similarly; however, the AT-MAS was not as efficacious as CPAP on resolving sleep-test parameters. The AT-MAS might be considered only a temporary treatment alternative. LEVEL OF EVIDENCE: 1b. Laryngoscope, 128:516-522, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Banhiran W, Assanasen P, Nopmaneejumrudlers C, et al. Adjustable thermoplastic oral appliance versus positive airway pressure for obstructive sleep apnea. Laryngoscope. 2017. PMID: 28714534. doi:10.1002/lary.26753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。